Discussion on improving the medical insurance access of high-value orphan drugs in China under the basic medical insurance system
ZHU Lin, HU Jiahao, LIU Yuhan, LI Fen, JIN Chunlin
Discussion on improving the medical insurance access of high-value orphan drugs in China under the basic medical insurance system
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |